Stay informed with the latest litigation news. Explore now

IP Verse

Lanyon Oppositions competitive analysis

Explore the latest publications and patents granted to Lanyon Oppositions, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Lanyon Oppositions against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 18, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 23, 2025
EP3853305	High-Purity Peg Lipids And Uses Thereof	MODERNATX	Jul 2, 2025
EP4241849	Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab	F HOFFMANN LA ROCHE	Jun 17, 2025
EP3589661	Adjuvant Treatment Of Her2-Positive Breast Cancer	F HOFFMANN LA ROCHE	Jul 31, 2024
EP3703818	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Jul 30, 2024
EP3626270	New Use	NOVARTIS	Jul 11, 2024

Discover the latest PTAB cases involving Lanyon Oppositions, highlighting their recent legal challenges and patent disputes.

Top competitors of Lanyon Oppositions based on patent oppositions.